The drug abatacept was shown to significantly reduce the risk of acute graft-versus-host disease (GVHD) among children and adults undergoing unrelated donor blood and marrow transplant for hematologic cancer during a seven-year, multisite trial.
College football fans fight childhood cancer by pledging donations throughout the season
ATLANTA (Oct. 27, 2020) – Children’s Healthcare of Atlanta has selected Janine Musholt to become the next President of the Children’s Healthcare of Atlanta Foundation. Musholt...
.relatedChild .image-icon { max-width: 65px !important; } ATLANTA (Oct. 21, 2020) – Teens undergoing posterior spinal fusion surgery for adolescent idiopathic scoliosis decreased...
Construction has begun on largest healthcare project in Georgia's history with $200 million donation from The Arthur M. Blank Family Foundation
ATLANTA (Oct. 5, 2020) – Children’s Healthcare of Atlanta, Emory University School of Medicine and Georgia Institute of Technology have received an additional $18.2 million from the...
The trial will utilize the national Pediatric Emergency Care Applied Research Network (PECARN)
ATLANTA (Sept. 21, 2020)–Delays in starting COVID-19 vaccine clinical trials in children will prolong overall recovery from the global pandemic, according to a new paper published in Clinical...
A Children’s Healthcare of Atlanta patient has become the youngest patient to date to receive experimental convalescent plasma transfusions to treat the novel coronavirus.
During the COVID-19 pandemic, it’s more important than ever to protect your family by staying on track with immunizations